vaccines
DomesticBiological Product
Recombinant Human Interferon α2b for Injection
北京远策药业有限责任公司
Drug Information
| Generic name | 注射用重组人干扰素α2b |
|---|---|
| Trade name | 远策素 |
| English name | Recombinant Human Interferon α2b for Injection |
| Dosage form | Injection (lyophilized) |
| Specification | (1)100万IU/支(2)300万IU/支 |
| Category | Biological Product |
| Approval no. | 国药准字S19990013 |
| Drug code | 86900214000035；86900214000073 |
| Manufacturer | 北京远策药业有限责任公司 |
| Production address | （生产地址）北京市北京经济技术开发区荣昌东街7号隆盛工业园9号厂房 |
| Origin | Domestic |
| Approval date | 2020-07-15 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.